Director or Officer Departures, Elections, Appointments, and Compensation Arrangements

Business Context and Reporting Period

This Form 8-K is a current report filed by Ekso Bionics Holdings, Inc. (not Chronoscale Holdings Corp) on December 5, 2014. The filing addresses corporate governance changes, specifically the expansion of the Board of Directors and the appointment of a new director.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.

Material Changes

  • Board Expansion: The Board of Directors voted to increase the number of directors from five to six.
  • New Appointment: Stanley Stern was elected as a director and a member of the Audit Committee. The Board determined Mr. Stern is an independent director meeting SEC and Nasdaq standards.
  • Compensation Arrangement: Mr. Stern was awarded an option to purchase 200,000 shares of common stock, exercisable over four years. He is also entitled to a $10,000 annual retainer plus a $5,000 annual retainer for his Audit Committee service.

Guidance, Outlook, and Risks

The filing contains no financial guidance, outlook, or management commentary regarding business operations. No specific risks or contingencies were disclosed in this report, other than the standard anticipation of entering into a director indemnification agreement.

Investor Verification Checklist

  • Verify the exact terms of the stock option grant for Stanley Stern (exercise price, vesting schedule) in the full compensation agreement.
  • Confirm the independence status of the new director against current Nasdaq listing standards.
  • Review the press release filed as Exhibit 99.1 for additional context on the appointment.
  • Note that this filing does not contain financial data; refer to the most recent 10-K or 10-Q for financial metrics.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.